Top compounds associated with response to TCEAL5


Feature Type Standardized
Nominal ANOVA
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.23 2e-11
mRNA PX-12 CTRPv2 pan-cancer AAC 0.18 6e-10
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 9e-10
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 2e-09
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.23 4e-09
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 4e-08
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.18 1e-07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.19 2e-07
Download CSV